JiangSu WuZhong Pharmaceutical Development (stock code: 600200.SH) forecasts a net profit of approximately 55 to 80 million yuan for the year 2024, turning losses into gains.

JiangSu WuZhong Pharmaceutical Development (600200.SH) has released its performance forecast for the year 2024. The company expects to achieve a net profit attributable to the shareholders of the listed company of approximately 55 to 80 million yuan in 2024, compared to a loss in the same period last year. It is also projected to achieve a net profit attributable to the shareholders of the listed company, excluding non-recurring gains and losses, of about 35 to 60 million yuan in 2024.